CommercialSeptember 1, 2020
Anthem Georgia preapproval list change notification 9/1/2020
AIM Specialty Health, a separate company, is a nationally recognized leader delivering specialty benefits management on behalf of Anthem for certain health plan members. Determine if preapproval is needed for a Georgia Anthem member by visiting the “Medical Policy and Clinical UM Guidelines” page on our provider website or by calling the preapproval phone number printed on the back of the member’s ID card. To submit your request for any of the services below, contact AIM online via AIM’s ProviderPortal at aimspecialtyhealth.com/goweb. From the drop-down menu, select GA. You may also call AIM toll-free at 866-714-1103, Monday – Friday, 8:00 a.m. – 6:00 p.m. ET
AIM provides benefits management for the programs listed below:
- Imaging Level of Care
- Genetic Testing>Diagnostic Imaging Management
- Cardiovascular Services
- Radiation Therapy Services
- Outpatient Sleep Testing and Therapy Services
- Cancer Care Quality Program
- Musculoskeletal (for Fully Insured)
- Upper Gastrointestinal Endoscopy
For more details on these programs, please visit the AIM Specialty Health® site at aimspecialtyhealth.com/marketing/guidelines/185/index.html. By clicking on the previous links, you will be directed to sites created and/or maintained by another, separate entity (“External Site”). Upon linking you are subject to the terms of use, privacy, copyright and security policies of the External Sites. We provide these links solely for your information and convenience. We encourage you to review the privacy practices of the External Sites. The information contained on the External Sites should not be interpreted as medical advice or treatment provided by us.
Eligibility and benefits
Eligibility and benefits can be verified by through anthem.com/provider or by calling the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved. Benefit plans vary widely and are subject to change based on the contract effective dates. The provider is responsible for verification of member eligibility and covered benefits. Except in the case of an emergency, failure to obtain preapproval prior to rendering the designated services listed below will result in denial of reimbursement.
MED.00132 Adipose-derived Regenerative Cell Therapy and Soft Tissue Augmentation Procedures |
11950, 11951, 11952, 11954, 15771, 15772, 15773, 15774, 31574, C1878, L8607, 0489T, 0490T, 0565T, 0566T, G0429, Q2026, Q2028 |
Add 11/1/2020 |
MED.00133 Ingestion Event Monitors |
99199, A9279 |
Add 11/1/2020 |
THER-RAD.00012 Electrophysiology-Guided Noninvasive Stereotactic Cardiac Radioablation |
77299, 77399 |
Add 11/1/2020 |
Codes added to existing preapproval documents |
||
CG-GENE-12 PIK3CA Mutation Testing for Malignant Conditions |
0177U |
Add 7/1/2020 |
CG-GENE-14 Gene Mutation Testing for Solid Tumor Cancer Susceptibility and Management |
81120, 81121, 81245, 81246, 81272, 81314, 0023U, 0046U, 0154U |
Add 11/1/2020 |
CG-GENE-16 BRCA Testing for Breast and/or Ovarian Cancer Syndrome |
0172U |
Add 7/1/2020 |
DME.00009 Vacuum Assisted Wound Therapy in the Outpatient Setting |
97607, 97608, A9272 |
Add 5/21/2020 |
DME.00011 Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices |
0278T |
Add 11/1/2020 |
GENE.00010 Panel and other Multi-Gene Testing for Polymorphisms to Determine Drug-Metabolizer Status |
0173U, 0175U |
Add 7/1/2020 |
GENE.00049 Circulating Tumor DNA Testing for Cancer (Liquid Biopsy) |
0179U |
Add 7/1/2020 |
LAB.00011 Analysis of Proteomic Patterns |
0174U |
Add 7/1/2020 |
MED.00004 Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy, Ultrasonography) |
96931, 96932, 96933, 96934, 96935, 96936 |
Add 11/1/2020 |
MED.00129 Gene Therapy for Spinal Muscular Atrophy |
J3399 |
Add 7/1/2020 |
SURG.00010 Treatments for Urinary Incontinence |
0596T, 0597T |
Add 7/1/2020 |
SURG.00011 Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft Tissue Grafting |
Q4227-Q4242, Q4244-Q4248 |
Add 7/1/2020 |
SURG.00126 |
0600T, 0601T |
Add 7/1/2020 |
SURG.00132 |
C9122 |
Add 7/1/2020 |
PUBLICATIONS: September 2020 Anthem Provider News - Georgia
To view this article online:
Or scan this QR code with your phone